Insider · CIK 0001211840

HURWITZ EDWARD

Reports to the SEC for 10 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001211840

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+35.2K sh	—	—	35,152
2026-05-19	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Director	AAward	+3,750 sh	—	—	3,750
2026-05-19	MGNXMACROGENICS INC · Stock Option (right to buy)A Award	Director	AAward	+22K sh	—	—	22,000
2026-05-18	MGNXMACROGENICS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,750 sh	—	—	47,824
2026-05-18	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,750 sh	—	—	0
2025-05-30	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2025-05-21	MGNXMACROGENICS INC · Stock Option (right to buy)A Award	Director	AAward	+22K sh	—	—	22,000
2025-05-21	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Director	AAward	+3,750 sh	—	—	3,750
2025-05-20	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,500 sh	—	—	0
2025-05-20	MGNXMACROGENICS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,500 sh	—	—	44,074
2024-05-22	DYNDyne Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+25.1K sh	—	—	25,133
2024-05-21	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Director	AAward	+6,500 sh	—	—	6,500
2024-05-21	MGNXMACROGENICS INC · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2024-05-20	MGNXMACROGENICS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,500 sh	—	—	37,574
2024-05-20	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,500 sh	—	—	0
2023-08-30	MGNXMACROGENICS INCP Purchase	Director	PPurchase	+15K sh	$4.91	+$73.7K	33,074
2023-05-31	MGNXMACROGENICS INC · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2023-05-31	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Director	AAward	+4,500 sh	—	—	4,500
2023-05-24	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.9K sh	—	—	24,900
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,688 sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,375 sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPU Disposition from Tender	Director	UDisposition from Tender	−1,800 sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,200 sh	—	—	0
2022-11-30	APPLIED GENETIC TECHNOLOGIES CORPU Disposition from Tender	Director	UDisposition from Tender	−25.7K sh	—	—	0
2022-06-03	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.6K sh	—	—	19,596
2022-05-19	MGNXMACROGENICS INC · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-11-30	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2021-05-26	DYNDyne Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.6K sh	—	—	19,596
2021-05-13	MGNXMACROGENICS INC · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-12-16	APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-09-21	DYNDyne Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−1.33M sh	—	—	0
2020-09-21	DYNDyne Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−276K sh	—	—	0
2020-09-21	DYNDyne Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−743K sh	—	—	0
2020-09-21	DYNDyne Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−14M sh	—	—	0
2020-09-21	DYNDyne Therapeutics, Inc.C Conversion	Director	CConversion	+245K sh	—	—	245,279
2020-09-21	DYNDyne Therapeutics, Inc.C Conversion	Director	CConversion	+4.61M sh	—	—	4,614,943
2020-09-21	DYNDyne Therapeutics, Inc.C Conversion	Director	CConversion	+91.1K sh	—	—	91,081
2020-09-21	DYNDyne Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−26.2K sh	—	—	0
2020-09-21	DYNDyne Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−70.5K sh	—	—	0
2020-08-07	DYNDyne Therapeutics, Inc. · Series B Preferred StockP Purchase	Director	PPurchase	+26.2K sh	$2.81	+$73.6K	26,176
2020-08-07	DYNDyne Therapeutics, Inc. · Series B Preferred StockP Purchase	Director	PPurchase	+70.5K sh	$2.81	+$198K	70,492
2020-08-07	DYNDyne Therapeutics, Inc. · Series B Preferred StockP Purchase	Director	PPurchase	+1.33M sh	$2.81	+$3.73M	1,326,313
2020-07-31	DYNDyne Therapeutics, Inc. · Series A Preferred StockP Purchase	Director	PPurchase	+96.6K sh	$1.00	+$96.6K	275,932
2020-07-31	DYNDyne Therapeutics, Inc. · Series A Preferred StockP Purchase	Director	PPurchase	+260K sh	$1.00	+$260K	743,076

Recent filings

Accepted (ET)
Jun 94
HURWITZ EDWARD0001193125-26-264031
SEC(opens sec.gov)
May 204
HURWITZ EDWARD0001211840-26-000002
SEC(opens sec.gov)
Jun 34
HURWITZ EDWARD0000950170-25-081360
SEC(opens sec.gov)
May 224
HURWITZ EDWARD0001125345-25-000078
SEC(opens sec.gov)
May 244
HURWITZ EDWARD0000950170-24-064726
SEC(opens sec.gov)
May 234
HURWITZ EDWARD0001125345-24-000127
SEC(opens sec.gov)
May 224
HURWITZ EDWARD0001125345-24-000101
SEC(opens sec.gov)
Sep 14
HURWITZ EDWARD0001125345-23-000111
SEC(opens sec.gov)
Jun 24
HURWITZ EDWARD0001125345-23-000099
SEC(opens sec.gov)
May 254
HURWITZ EDWARD0001209191-23-032274
SEC(opens sec.gov)
Dec 14
HURWITZ EDWARD0001062993-22-023026
SEC(opens sec.gov)

Companies

Address

C/O DYNE THERAPEUTICS, INC. 1560 TRAPELO ROAD

WALTHAM, MA, 02451